Skip to content

Clinical trials

Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor Cell Lymphoblastic Leukemia-Lymphoma Country / region: Australia Clear all

91 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20025
20032
20042
20055
20063
20073
20084
20093
20103
20113
20121
20133
20144
20155
20176
20184
20194
20201
20212
20226
20232
20243
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed58
Recruiting16
Active, not recruiting8
Terminated7
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Oncology Group29
Therapeutic Advances in Childhood Leukemia Consortium8
Novartis Pharmaceuticals6
Amgen5
Bristol-Myers Squibb4
National Cancer Institute (NCI)4
AbbVie3
Allotera Therapeutics2
AstraZeneca2
Charite University, Berlin, Germany2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma91
Leukemia29
Recurrence14
Leukemia, Myeloid, Acute13
Burkitt Lymphoma11
Leukemia, Biphenotypic, Acute10
Lymphoma8
Lymphoma, Non-Hodgkin8
Myelodysplastic Syndromes8
Leukemia, Lymphocytic, Chronic, B-Cell6

Trials

Showing 26 to 50 of 91. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.